Viemed Healthcare, Inc.
VMD· Nasdaq
Released Nov 6, 2024, after the close
10-Q filed Nov 6, 2024, 37 days after period end · 0001729149-24-000210
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $58.00M | $49.40M | $35.76M | $29.29M |
| Net Income | $3.88M | $2.92M | $1.06M | $1.79M |
| EPS Diluted |
Viemed Healthcare, Inc. · CIK 1729149 · Engraved from SEC EDGAR
| $0.10 |
| $0.07 |
| $0.03 |
| $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.